KVUE:NYSE
Kenvue Inc
17,91Â US$
arrow_upward
+0,17%(+0,030) 1D
17,91Â US$
0,00% (0,00)
bedtimeEftermarked
Lukket: 29. sep., 16.00.05 GMT-4 · USD
search
Alle symboler
1D
5D
1M
6M
Ã…TD
1Ã…
5Ã…
MAKS
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for KVUE...
Ã…bn
17,74Â US$
Høj
17,93Â US$
Lav
17,70Â US$
Markedsværdi
34,40Â mia.
Gns. vol.
24,86Â mio.
Volumen
150,00
Udbytte
4,69Â %
Kvartalsvis udbytte
0,21Â US$
Ex-dato
21. sep. 2026
P/E-forhold
20,76
Højeste i 52 uger
20,13Â US$
Laveste i 52 uger
14,02Â US$
Indtægt pr. aktie
0,86Â US$
Beta
0,46
Aktier i omløb
1,92Â mia.
Antal ansatte
22Â t
Ã…bn
17,74Â US$
Høj
17,93Â US$
Lav
17,70Â US$
Markedsværdi
34,40Â mia.
Gns. vol.
24,86Â mio.
Volumen
150,00
Udbytte
4,69Â %
Kvartalsvis udbytte
0,21Â US$
Ex-dato
21. sep. 2026
P/E-forhold
20,76
Højeste i 52 uger
20,13Â US$
Laveste i 52 uger
14,02Â US$
Indtægt pr. aktie
0,86Â US$
Beta
0,46
Aktier i omløb
1,92Â mia.
Antal ansatte
22Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Investing.com Canada
·
for 1 time siden
Kenvue brands present skin and hair research at Vienna congress By Investing.com
Investing.com Canada
·
for 11 timer siden
Form 4 Kenvue Inc For: 29 September By Investing.com
Stock Titan
·
for 15 timer siden
1,461 shares withheld for taxes on a Kenvue (KVUE) executive’s stock awards
TipRanks
·
for 1 dag siden
Kimberly-Clark Launches Kenvue Note Exchange and Consent
Profil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Om Kenvue Inc
Administrerende direktørKirk Perry
Ansatte21,9Â t
Grundlagt2022
HovedsædeSummit, New Jersey, USA
SektorPersonal care products
Websitekenvue.com